Skip to content

Post-Market Clinical Follow-up Study to evaluate the clinical safety and performance of the 5C® MEDic knee system

Post-Market Clinical Follow-up Study to evaluate the clinical safety and performance of the 5C® MEDic knee system

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00038507
Enrollment
100
Registered
2025-11-20
Start date
2025-11-24
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee TEP

Interventions

Group 1: PMCF study (monocentric, prospective, non-interventional, single-armed) data: revisions incl. reasons, complications, joint function, quality of life, radiological evaluation (if X-rays avai

Sponsors

implantcast GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - The written Informed Consent Form (ICF) is signed by the patient prior to any study-specific actions. - The patient will be operated at the St. Josef hospital Werden. - The patient will receive the 5C® MEDic Knee System (manufactured by implantcast GmbH). - The implantation will be performed according to the medical indications listed in the product-specific Instruction for Use (IFU). - The patient is willing and able to attend the follow-up visits at the study site (clinics / hospital) and agrees to be contacted by telephone or by mail.

Exclusion criteria

Exclusion criteria: - No Informed Consent Form (ICF) signed by the patient is available - The patient has a tumor at the time of the examination (not tumor-free in the last 5 years). - Adipositas permagna - age > 99 years at enrolment - Current infection as well as infections close to the knee joint within the last 3 years - Known allergy to any of the implant materials - The female patient is pregnant at time of the implantation. - The patient is a minor (skeletally immature), incapable of giving consent, legally incompetent, or limited in his legal capacity. - There are indications that the patient will not comply with the study protocol. - Alcohol and/or drug abuse or other addictions that might impair the patient’s capacity to estimate the nature and the scope of the study - The patient participated in another clinical study within the last four weeks before inclusion in this PMCF study.

Design outcomes

Primary

MeasureTime frame
Evaluation of the clinical safety of the 5C® MEDic knee system based on the revision rate.

Secondary

MeasureTime frame
Evaluation of the clinical performance of the 5C® MEDic knee system

Countries

Germany

Contacts

Public ContactImke Bokelmann

implantcast GmbH

clinicalstudies@implantcast.de+4941617440

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026